All filters
Abstracts
Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH
D. Armenia
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients
C. Valente
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway
R. Leiva
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability
J. Jeffrey
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV evolution in patients initiating antiretroviral therapy during primary infection
B. Abdi
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance
L. Kostrikis
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence
A. Antonova
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Phylogenetic analyses applied to the study of transmission variants in a HIV-1 positive couple
A. BergnaÂ
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Unexpected rising in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
M. Alkhatib
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Enduring Materials | Dr. Lichterfeld | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Scarsi | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Rubin | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Kozal | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Jilich | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Hill | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Flexner | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Flexner | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Descamps | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Coll | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Calcagno | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020
Videos
Enduring Materials | Dr. Boesecke | European HIV Clinical Forum 2020
Presented at:
European HIV Clinical Forum 2020